Villamor, Orle A.

HRN: 17-92-62  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2025
CEFUROXIME 1.5GM (VIAL)
01/21/2025
01/28/2025
IV
1.5gm As LD Then 750mg
Q8
SP ORIF
Rejected 

 Indication:  Prophylaxis    Type of Infection:  Bone & Joint    Compliance to guidelines: Non-compliant To Guidelines